Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally?

Published:2020-12 Issue:12 Volume:124 Page:1297-1309
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Kanavos Panos,Kamphuis Bregtje W.,Fontrier Anna-Maria,Colville Parkin Georgia,Saleh Shadi,Akhras Kasem S.

Funder

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

Elsevier BV

Subject

Health Policy

Reference45 articles.

1. World Bank DataBank: World Development Indicators;World Bank,2019

2. Implications of external price referencing of pharmaceuticals in Middle East countries;Kaló;Expert Review of Pharmacoeconomics & Outcomes Research,2015

3. Assessment of the current pricing policy on the pharmaceutical sector;Qarain;USAID,2009

4. Egypt: Pharmaceuticals & Healthcare Report Q1 2018. Industry Report & Forecasts Series;Business Monitor International (BMI),2017

5. Jordan: Pharmaceuticals & Healthcare Report Q1 2018. Industry Report & Forecasts Series;Business Monitor International (BMI),2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adapting global evidence-based practice guidelines to the Egyptian healthcare context: the Egyptian Pediatric Clinical Practice Guidelines Committee (EPG) initiative;Bulletin of the National Research Centre;2023-06-13

2. Genuine policy learning is fundamental: the journey of the United Arab Emirates toward the establishment of health technology assessment;International Journal of Technology Assessment in Health Care;2023

3. Institutionalizing health technology assessment in Egypt: Situational analysis and roadmap;Frontiers in Pharmacology;2022-11-09

4. Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration;Health Policy OPEN;2021-12

5. A case for external reference pricing to regulate drug costs in low- and middle-income countries;British Journal of Healthcare Management;2021-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3